Literature DB >> 9635197

Two phases of Hox gene regulation during early Xenopus development.

M E Pownall1, H V Isaacs, J M Slack.   

Abstract

We have shown previously that fibroblast growth factor (FGF) signalling in posterior regions of the Xenopus embryo is required for the development of the trunk and tail via a molecular pathway that includes the caudal-related gene Xcad3 and the posterior Hox genes [1]. These results have been contested by the work of Kroll and Amaya [2], which shows that Xenopus embryos transgenic for a dominant-negative form of the FGF receptor (FGF-RI) express posterior Hox genes normally, leading these authors to suggest that the FGFs are not required for anteroposterior (A-P) patterning of the dorsal axis. In order to investigate the apparent discrepancy between these studies, we have produced Xenopus embryos transgenic for two inhibitors of the FGF/Caudal pathway: a kinase-deficient dominant-negative FGF receptor (XFD) [3]; and a domain-swapped form of Xcad3 (Xcad-EnR) in which the activation domain of Xcad3 is replaced by the repression domain of the Drosophila Engrailed protein. Both of these were introduced as fusions with the green fluorescent protein (GFP), which allows identification of non-mosaic transgenic embryos at early gastrula stages by simply looking for GFP fluorescence. Analysis of gene expression in embryos transgenic for these constructs indicated that the activation of posterior Hox genes during early neurula stages absolutely requires FGF signalling and transcriptional activation by Xcad3, while the maintenance of Hox gene expression in the trunk and tail during later development is independent of both FGF and Xcad.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9635197     DOI: 10.1016/s0960-9822(98)70257-x

Source DB:  PubMed          Journal:  Curr Biol        ISSN: 0960-9822            Impact factor:   10.834


  19 in total

1.  Aiolos transcription factor controls cell death in T cells by regulating Bcl-2 expression and its cellular localization.

Authors:  F Romero; C Martínez-A; J Camonis; A Rebollo
Journal:  EMBO J       Date:  1999-06-15       Impact factor: 11.598

2.  Easy passage: germline transgenesis in frogs.

Authors:  K L Kroll; M W Kirschner
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-07       Impact factor: 11.205

Review 3.  Origins of anteroposterior patterning and Hox gene regulation during chordate evolution.

Authors:  T F Schilling; R D Knight
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-10-29       Impact factor: 6.237

4.  Fgfr1 regulates patterning of the pharyngeal region.

Authors:  Nina Trokovic; Ras Trokovic; Petra Mai; Juha Partanen
Journal:  Genes Dev       Date:  2003-01-01       Impact factor: 11.361

5.  Regulation of Hox gene expression and posterior development by the Xenopus caudal homologue Xcad3.

Authors:  H V Isaacs; M E Pownall; J M Slack
Journal:  EMBO J       Date:  1998-06-15       Impact factor: 11.598

6.  New roles for Wnt and BMP signaling in neural anteroposterior patterning.

Authors:  Hanna Polevoy; Yoni E Gutkovich; Ariel Michaelov; Yael Volovik; Yaniv M Elkouby; Dale Frank
Journal:  EMBO Rep       Date:  2019-04-01       Impact factor: 8.807

Review 7.  Signaling gradients during paraxial mesoderm development.

Authors:  Alexander Aulehla; Olivier Pourquié
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-02       Impact factor: 10.005

8.  Active repression of RAR signaling is required for head formation.

Authors:  T Koide; M Downes; R A Chandraratna; B Blumberg; K Umesono
Journal:  Genes Dev       Date:  2001-08-15       Impact factor: 11.361

9.  Xenopus Sprouty2 inhibits FGF-mediated gastrulation movements but does not affect mesoderm induction and patterning.

Authors:  S L Nutt; K S Dingwell; C E Holt; E Amaya
Journal:  Genes Dev       Date:  2001-05-01       Impact factor: 11.361

10.  Mitogen-activated protein kinase and neural specification in Xenopus.

Authors:  A R Uzgare; J A Uzman; H M El-Hodiri; A K Sater
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.